Zomedica Corp. (ZOM): Price and Financial Metrics

Zomedica Corp. (ZOM): $0.14

0.00 (-0.57%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

F

ZOM Price/Volume Stats

Current price $0.14 52-week high $0.25
Prev. close $0.14 52-week low $0.12
Day low $0.14 Volume 2,537,100
Day high $0.14 Avg. volume 5,401,754
50-day MA $0.13 Dividend yield N/A
200-day MA $0.17 Market Cap 135.72M

ZOM Stock Price Chart Interactive Chart >


Zomedica Corp. (ZOM) Company Bio


Zomedica Pharmaceuticals Corp. operates as a veterinary pharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such as canine, feline, and equine. The company has a research collaboration agreement with Celsee Diagnostics, Inc. to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostics. Zomedica Pharmaceuticals Corp. was founded in 2015 and is based in Ann Arbor, Michigan.


ZOM Latest News Stream


Event/Time News Detail
Loading, please wait...

ZOM Latest Social Stream


Loading social stream, please wait...

View Full ZOM Social Stream

Latest ZOM News From Around the Web

Below are the latest news stories about ZOMEDICA CORP that investors may wish to consider to help them evaluate ZOM as an investment opportunity.

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease

ANN ARBOR, MI / ACCESSWIRE / December 18, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced ...

Yahoo | December 18, 2023

Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners

ANN ARBOR, MI / ACCESSWIRE / December 6, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced ...

Yahoo | December 6, 2023

Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference

ANN ARBOR, MI / ACCESSWIRE / November 28, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today announced that ...

Yahoo | November 28, 2023

Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference

ANN ARBOR, MI / ACCESSWIRE / November 20, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today announced that ...

Yahoo | November 20, 2023

Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated ...

Yahoo | November 13, 2023

Read More 'ZOM' Stories Here

ZOM Price Returns

1-mo 0.72%
3-mo -17.40%
6-mo -16.96%
1-year -37.44%
3-year -86.00%
5-year -59.67%
YTD -30.07%
2023 22.82%
2022 -46.82%
2021 32.91%
2020 -30.33%
2019 -73.09%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!